Pipeline Previews

By No Comments
ONRELTEAGalderma Canada Inc., has announced that ONRELTEA™ topical gel (Brimonidine gel 0.33%) has been approved by Health Canada and is now available for Canadian patients 18 and older to treat…
Read More

Clinical Trial Reviews

By No Comments
Phase IIa, Randomized, Double-Blind, Placebocontrolled, Multicenter Study to Assess the Safety, Tolerability, and Preliminary Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa Sponsored by AstraZeneca, the purpose…
Read More